A combination treatment of c-myc antisense DNA with all-trans-retinoic acid inhibits cell proliferation by downregulating c-myc expression in small cell lung cancer

Antisense and Nucleic Acid Drug Development

Volumn 10, Issue 4, 2000, Pages 243-249

  Akie, K ^a   Dosaka Akita, H ^a   Murakami, A ^b   Kawakami, Y ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b KYOTO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; OLIGODEOXYNUCLEOTIDE; RETINOIC ACID;

ARTICLE; CANCER RECURRENCE; CELL PROLIFERATION; CONTROLLED STUDY; DENSITOMETRY; DOWN REGULATION; GENE CONTROL; GENE THERAPY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LUNG SMALL CELL CANCER; ONCOGENE C MYC; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0033817542     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/108729000421420     Document Type: Article

References (39)

1. Analysis of small cell lung cancer cell growth inhibition by 13-cis-retinoic acid: Importance of bioavailability
2. Protein kinase C-β2 inhibits cycling and decreases c-myc-induced apoptosis in small cell lung cancer cells
3. Effect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivo
4. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism
5. c-myc Antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice
6. The myc oncogene: Its role in transformation and differentiation
7. Preparation and analysis of RNA from eukaryotic cells
8. myc Family oncogene in the development of normal and neoplastic cells
9. Inhibition of proliferation by L-myc antisense DNA for the translational initiation site in human small cell lung cancer
10. Differentiation of human variant small cell lung cancer cell lines to a classic morphology by retinoic acid
11. Human lung cancer cell lines exhibit resistance to retinoic acid treatment
12. Report of a meeting: Molecular basis of cancer therapy
13. Proteins of the Myc network: Essential regulators of cell growth and differentiation
14. Chemotherapy of lung cancer
15. The human L-myc gene is expressed as two forms of protein in small cell lung carcinoma cell lines: Detection by monoclonal antibodies specific to two myc homology box sequences
16. bcl-2 Antisense therapy chemosensitizes human melanoma in SCID mice
17. The role of myc, jun, and fos oncogenes in human lung cancer
18. myc Family oncogen amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course
19. All-trans-retinoic acid alters myc gene expression and inhibits in vitro progression in small cell lung cancer
20. Growth inhibition and induction of apoptosis by fenretinide in small cell lung cancer cell lines
21. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and in mice
22. Novel retinoid-related molecules as apoptosis inducers and effective inhibitors of human lung cancer cells in vivo
23. myc Function and regulation
24. In pursuit of antisense
25. Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c-myc antisense oligonucleotide
26. Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotides
27. Mechanism of all-trans-retinoic acid-mediated L-myc gene regulation in small cell lung cancer
28. c-myc Antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer
29. myc Genes and their deregulation in lung cancer
30. Leukemia treatment in severe combined immunodeficiency mice by antisense oligodeoxynucleotides targeting cooperating oncogenes
31. Treatment of Philadelphia leukemia in severe combined immunodeficient mice by combination of cyclophosphamide and bcr/abl antisense oligodeoxynucleotides
32. Antisense oligodeoxynucleotide combination therapy of primary chronic myelogenous leukemia blast crisis in SCID mice
33. Antisense c-myc and immunostimulatory oligonucleotide inhibition of tumorigenesis in a murine B-cell lymphoma transplant model
34. Antisense oligonucleotides as therapeutic agents - Is the bullet really magical?
35. Differential effects of synergistic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells
36. Effects of an inducible anti-sense c-myc gene transfer in a drug-resistant human small-cell lung carcinoma cell line
37. Gene inhibition using antisense oligodeoxynucleotides
38. Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer
39. Human promyelocytic leukemia HL-60 cell proliferation and c-Myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA